Abstract
Neutrophils possess potently active biological systems able to kill in vitro tumors as well as a wide range of microorganisms, including bacteria, fungi [1-3], and viruses [4-6]. To this end, neutrophils utilize directly microbicidal granule proteins as well as a variety of reactive oxygen intermediates. However, the most efficient oxygen-dependent system exploits the combined effects of hydrogen peroxide, generated by activation of the NADPH-dependent oxidase, and the granule protein myeloperoxidase (MPO; E.C. 1.11.1.7).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Klebanoff SJ (1990) Myeloperoxidase - occurrence and biological function. In: Everse J, Grisham M (eds) Peroxidase in chemistry and biology. CRC Press, Boca Raton, 180–192
Klebanoff SJ (1980) Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 93:480–489
Clark RA, Klebanoff SJ, Einstein AB, Fefe A (1975) Peroxidase H202-halide system: cytotoxic effect on mammalian tumor cells. Blood 45:161
Yamamoto K, Suzuki K, Suzuki K, Mizuno S (1989) Phagocytosis and ingestion of influenza virus by human polymorphonuclear leukocytes in vitro: electron microscopy studies. J Med Microbiol 28: 191–198
Yamamoto K, Miyoshi-Koshio T, Utuki Y, Mizuno S, Suzuki K (1991) Virucidal activity and viral protein modification by myeloperoxidase: a candidate for defense factor of human polymorphonuclear leukocytes against influenza infection. J Infect Dis 164: 8–14
Klebanoff SJ, Coobes RW (1992) Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1: role of the myeloperoxidase system. J Clin Invest 89: 2014–2017
Kutter D, Haidari AI, Thoma J (1994) Myeloperoxidase deficiency: simple methods for its diagnosis and significance of different forms. Klin Lab 40: 342–346
Ornstein L, Ansley H, Saunders A (1976) Improving manual differential white cell counts with cytochemistry. Blood Cells z: 557–585
Patriarca P, Cramer R, Tedesco F, Kakinuma K (1975) Studies on the mechanism of metabolic stimulation in polymorphonuclear leukocytes during phagocytosis. II. Presence of the NADPH oxidizing activity in a myeloperoxidase-deficient subject. Biochim Biophys Acta 385: 387–393
Nauseef WM, Root RK, Malech HL (1983) Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest 71:1297–1307
Inazawa J, Inoue K, Nishigaki H, Tsuda S, Taniwaki M, Misawa S, Abe T (1989) Assignment of the human myeloperoxidase gene (MPO) to bands q21.3-q23 of chromosome 17. Cytogenet Cell Genet 50: 135–136
Nauseef WM (1986) Myeloperoxidase biosynthesis by a human promyelocytic leukemia cell line: insight into myeloperoxidase deficiency. Blood 67: 865–872
Tobler A, Selsted ME, Miller CW, Johnson K.R, Novotny MI, Rovera G, Koeffler HP (1989) Evidence for a pretranslational defect in hereditary and acquired myeloperoxidase deficiency. Blood 73:1980–1986
Andrew PC, Krinsky NI (1981) The reductive cleavage of myeloperoxidase in half, producing enzymatically active hemi-myeloperoxidase. J Biol Chem 256: 4211–4218
Anderson MR, Atkin CL, Eye HJ (1982) Intact form of myeloperoxidase from normal human neutrophils. Arch Biochem Biophys 214: 273–283
Olsen RL, Little C (1984) Studies on the subunits of human myeloperoxidase. Biochem J 220: 701–709
Chang KS, Trujillo JM, Cook RG, Stass SA (1986) Human myeloperoxidase gene: molecular cloning and expression in leukemia cells. Blood 68: 1411–1414
Suzuki K, Yamaha M, Abash K, Fujikura T (1986) Similarity of kinetics in three types of myeloperoxidase of human leukocytes and four types of HL-6o cells. Arch Biochem Biophys 245: 167–173
Homma T, Suzuki K, Kudo Y, Inagawa M, Mizuno S, Yamaguchi K, Tagawa M (1989) Preparation and characterization of monoclonal antibodies against human myeloperoxidase. Arch Biochem Biophys 273: 189–196
Nauseef WM, Cogley M, McCormick S (1996) Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase. J Biol Chem 271: 9546–9549
Nauseef WM, Brigham S, Cogley M (1994) Hereditary myeloperoxidase deficiency due to a missense mutation of arginine 569 to tryptophan. J Biol Chem 269:1212–1216
Nauseef WM, Cogley M, Bock S, Petrides PE (1998) Pattern of inheritance in hereditary myeloperoxidase deficiency associated with R569W missense mutation. J Leukoc Biol 63: 264–269
DeLeo FR, Goedken M, McCormick SJ, Nauseef WM (1998) A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation. J Clin Invest 101: 2900–2909
Romano M, Dri P, Dadal L, Patriarca P (1997) Biochemical and molecular characterization ofhereditary myeloperoxidase deficiency. Blood 90: 4126–4134
Lanza F (1998) Clinical manifestations of myeloperoxidase deficiency. J Mol Med 76: 676–681
Aratani Y, Koyama H, Nyui S-I, Suzuki K, Kura F, Maeda N (1999) Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67:1828–1836
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Suzuki, K., Nunoi, H., Miyazaki, M., Koi, F. (2000). Prevalence of Inherited Myeloperoxidase Deficiency in Japan. In: Petrides, P.E., Nauseef, W.M. (eds) The Peroxidase Multigene Family of Enzymes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58314-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-58314-8_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63535-9
Online ISBN: 978-3-642-58314-8
eBook Packages: Springer Book Archive